SCHEMBL6699952

SCHEMBL6699952

CCOC(=O)COc1ccc(C=Cc2ccccc2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RELA Q04206 1/20 0.65
MAPT P10636 2/20 0.59
HPGD P15428 2/20 0.59
KDM4E B2RXH2 2/20 0.59
ALDH1A1 P00352 2/20 0.59
TP53 P04637 1/20 0.59
HSD17B10 Q99714 1/20 0.59
GAA P10253 1/20 0.59
NPSR1 Q6W5P4 1/20 0.59
PTGS2 P35354 1/20 0.56
RAB9A P51151 2/20 0.55
MAOA P21397 1/20 0.55
MAOB P27338 1/20 0.55
NPC1 O15118 1/20 0.55
KMT2A Q03164 1/20 0.55
CTDSP1 Q9GZU7 1/20 0.55
PPARA Q07869 2/20 0.54
NR1H4 Q96RI1 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6699950 1.00 RELA (0.65) RELAMAPTHPGDKDM4EALDH1A1
SCHEMBL20024754 0.94 GAA (0.66) RELAMAPTHPGDKDM4EALDH1A1
SCHEMBL20024726 0.88 GAA (0.59) RELAMAPTHPGDKDM4EALDH1A1
SCHEMBL377638 0.87 GAA (0.65) MAPTHPGDKDM4EALDH1A1TP53
SCHEMBL6645865 0.86 GAA (0.57) MAPTHPGDKDM4EALDH1A1TP53
SCHEMBL14533435 0.86 GAA (0.57) RELAMAPTHPGDKDM4EALDH1A1
SCHEMBL6645861 0.86 GAA (0.57) MAPTHPGDKDM4EALDH1A1TP53
SCHEMBL14506312 0.86 GAA (0.57) RELAMAPTHPGDKDM4EALDH1A1
SCHEMBL14506316 0.86 GAA (0.57) RELAMAPTHPGDKDM4EALDH1A1
SCHEMBL4105776 0.86 GAA (0.60) MAPTHPGDKDM4EALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040235022-A1 Quality control method for manufacturing biopolymer arrays ROCHE DIAGNOSTICS GMBH (DE) 2004-11-25 US disclosed
EP-1466663-A1 Quality control method for manufacturing nucleic acid arrays F. HOFFMANN-LA ROCHE AG (CH) 2004-10-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040235022-A1 Quality control method for manufacturing biopolymer arrays CTRL, PCBP1, PARG RELA 4266/4885MAPT 2010/4885HPGD 3928/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.